AUGS members are represented by a 13-member Board of Directors who is responsible for setting the overall strategic direction of the society. The Board is comprised of five officers and eight Directors-at-Large. The officers of the Society include a President, President-Elect, Vice President, Immediate Past President and a Treasurer.

Terms expire at the conclusion of the annual scientific meeting for the year indicated.

AUGS members can send communications to the Board of Directors using the board@augs.org email address. 

Officers

 

President

Geoffrey W. Cundiff, MD, FACOG, FACS, FRCSC
University of British Columbia
Vancouver, BC Canada
Term Expires: 2019

Corporate Disclosures: None

 

 

President Elect

Shawn A. Menefee, MD
Kaiser Permanente, San Diego
San Diego, CA
Term Expires: 2019

Corporate Disclosures: Author Royalties - UptoDate

 

 

 

Vice President

Holly Richter, PhD, MD
University of Alabama at Birmingham
Birmingham, AL
Term Expires: 2019

Corporate Disclosures: Research Grant - Pelvalon; Consultant/Advisory Board - Pelvalon, Renovia, BlueWind Medical; Author Royalties - BlueWind Medical, UptoDate

 

 

 

Treasurer

Michael K. Flynn, MD, MS
University of Massachusetts 
Worcester, MA
Term Expires: 2021

Corporate Disclosures: None

 

 

 

Immediate Past President

Charles R. Rardin, MD, FACOG, FACS
Alpert Medical School of Brown University
Providence, RI
Term Expires: 2019

Corporate Disclosures: Research Grant - Solace Therapeutics, Foundation for Female Health Awareness; Speaker's Bureau - Symposia Medicus
 

 

 

Directors-at-Large

 

 

Tanaz R. Ferzandi, MD
Tufts Medical Center
Boston, MA
Term Expires: 2021

Corporate Disclosures: Consultant/Advisory Board - Hologic, Inc. 

 

 

 

Lieschen H. Quiroz, MD
Oklahoma University Health Sciences Center
Oklahoma City, OK
Term Expires: 2021

Corporate Disclosures: Research Grants - Pelvalon, Cook

 

 

 

Eric R. Sokol, MD
Stanford University School of Medicine
Stanford, CA
Term Expires: 2020

Corporate Disclosures: Research Grants - ACell, Coloplast, Cook, Foundation for Female Health Awareness; Stock Holdings - Pelvalon

 

 

Elisa R. Trowbridge
University of Virginia
Charlottesville, VA
Term Expires: 2020

Corporate Disclosures: None

 

 

 

Jennifer M. Wu, MD, MPH
UNC-Chapel Hill
Chapel Hill, NC
Term Expires: 2019

Corporate Disclosures: Personal relationship with employee - United Therapeutics; Research Grants - Pelvalon, Boston Scientific

 

 

 

PFD Research Foundation Chair

Karen L. Noblett, MD
Axonics Medical Technologies
Irvine, CA
Term Expires: 2019

Corporate Disclosures: Research Grants - Boston Scientific; Employment - Axonics

 

 

 

 

PFD Research Foundation Vice Chair

Christopher M. Tarnay, MD
UCLA School of Medicine
Los Angeles, CA
Term Expires: 2019

Corporate Disclosures: None
 

 

 

Ex-Officio Members

 

 

AUGS Executive Director

Michelle Zinnert, CAE

American Urogynecologic Society

Silver Spring, MD

 

 

 

ACOG Representative

Charles C. Kilpatrick, MD
Baylor College of Medicine
Houston, TX
Term Expires: 2019

Corporate Disclosures: Author Royalties - UptoDate, McGraw Hill

 

 

 

ABOG Representative

Marlene Corton, MD, MS
UT Southwestern Medical Center
Dallas, TX
Term Expires: 2021